Canada's Only Single-Dose Cholera Vaccine Available Nationwide [Financial Post (Toronto, Ontario, Canada)]
BAVARIAN NORDIC R/I S/ADR (BVNRY)
NASDAQ:AMEX Investor Relations:
bavarian-nordic.com/investor.aspx
Company Research
Source: Financial Post
TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Bavarian Nordic, a leading global supplier of travel vaccines, today announced the commercial availability of VAXCHORA ® —the only single-dose oral vaccine approved in Canada to protect against cholera, a sudden and serious intestinal infection marked by acute watery diarrhea. For approximately 1 in 10 people infected with cholera, a severe presentation of cholera can rapidly cause severe dehydration and death if left untreated Cholera is endemic to approximately 50 countries , and cholera outbreaks are most common in parts of Asia, Africa and Central and South America . Approximately 1.3 million – 4 million cases of cholera occur worldwide each year . The World Health Organization estimates that only 5-10% of actual worldwide cases of cholera are reported . While most commonly transmitted by consuming contaminated water, cholera may also be acquired from eating contaminated raw or undercooked food, especially fish and shellfish “Canad
Show less
Read more
Impact Snapshot
Event Time:
BVNRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVNRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVNRY alerts
High impacting BAVARIAN NORDIC R/I S/ADR news events
Weekly update
A roundup of the hottest topics
BVNRY
News
- US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- IDWeek 2024: strategic approaches and challenges in mpox vaccination [Yahoo! Finance]Yahoo! Finance
- Is Bavarian Nordic (BVNRY) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic's mpox vaccine to be trialled in pregnant women and infants [Yahoo! Finance]Yahoo! Finance